Hao Tan is a prominent inventor based in Zhejiang, China, known for his significant contributions to pharmaceutical chemistry. With a total of five patents to his name, he has made strides in developing compounds that serve as potential agents for chemotherapy.

Latest Patents

Hao Tan's latest patents include innovative compounds that act as NAMPT inhibitors. One of his notable inventions is a pyrrolidine derivative, which is designed to enhance water solubility and reduce synthesis difficulty, making it more suitable for industrial production. This compound is aimed at treating diseases associated with abnormal NAD expression. Another significant patent is the pyridinylcyanoguanidine derivative, which also functions as an NAMPT inhibitor. This derivative improves upon previous structures by enhancing affinity with NAMPT and addressing solubility issues, thereby facilitating drug testing.

Career Highlights

Throughout his career, Hao Tan has worked with various companies, including Rushi Biotech (Hangzhou) Co., Ltd. His work has focused on optimizing drug compounds to improve their efficacy and usability in medical applications.

Collaborations

Hao Tan has collaborated with notable colleagues such as Zheming Wang and Ping Zhao, contributing to the advancement of pharmaceutical innovations.

Conclusion

Hao Tan's work in developing NAMPT inhibitors showcases his dedication to improving therapeutic options for patients. His innovative approach to pharmaceutical chemistry continues to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com